08.02.2013 Views

functional medicine and nutritional genomics - American Association ...

functional medicine and nutritional genomics - American Association ...

functional medicine and nutritional genomics - American Association ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

AAPI’S NUTRITION GUIDE TO OPTIMAL HEALTH: USING PRINCIPLES OF FUNCTIONAL MEDICINE AND NUTRITIONAL GENOMICS<br />

The use of HBO in the acute closed head injury<br />

was studied in 1992 by Rockswold et al. when<br />

they r<strong>and</strong>omly selected for HBO treatment from<br />

168 patients who had a Glascow Coma Score of<br />

9 or less for at least 6 hours. HBOT did not<br />

increase the number of patients in the favorable<br />

outcome category. (6) It is now believed that<br />

there is a therapeutic window of between three<br />

<strong>and</strong> 6 hours for the treatment of TBI with<br />

HBOT(7), although delayed multiple HBO<br />

treatment may be beneficial.(8)<br />

HBO can protect the nervous system by improving<br />

brain metabolism, decreasing intracranial pressures,<br />

blunting the inflammatory response, improving the<br />

integrity of the blood brain barrier <strong>and</strong> reducing<br />

edema, <strong>and</strong> mitigating apoptosis.(9) HBOT was<br />

found to improve cerebral blood flow, as<br />

determined by SPECT scan, in a study of 50<br />

patients with chronic brain injury (10) An<br />

improvement in aerobic brain metabolism was seen<br />

in 37 severely brain injured patients after they<br />

underwent up to seven one-hour treatments<br />

with HBOT. These authors demonstrated a<br />

reduction in cerebrospinal fluid lactate, a reduction<br />

in intracranial pressure, <strong>and</strong> an increased cerebral<br />

metabolic rate.(11) None of these studies looked<br />

at clinical outcomes.<br />

Longhi et al. reported later that there was no<br />

evidence of a clinical benefit of hyperoxia<br />

for head injury, demonstrating that the ratio<br />

between lactate <strong>and</strong> pyruvate, which they<br />

deemed a better indicator of brain metabolism,<br />

was unchanged after hyperoxia (not<br />

HBOT).(12)<br />

In a review of the literature, McDonagh et al.<br />

reported in 2004 that the clinical significance of<br />

HBOT on <strong>functional</strong> status was ‚unclear,‛ but that<br />

the evidence did support a small decrease in<br />

overall mortality.(13) Shi et al., however,<br />

concluded that HBO therapy had ‚specific curative<br />

effects‛ after studying the use of HBO therapy<br />

in320 patients post-brain injury. They measured<br />

the recovery of clinical symptoms, control of<br />

epilepsy, <strong>and</strong> resolution of hydrocephalus. SPECT<br />

imaging was performed before <strong>and</strong> after treatment<br />

to assess the therapeutic effects of HBOT. These<br />

147<br />

authors concluded HBO therapy was superior to<br />

medications alone <strong>and</strong> that SPECT imaging could<br />

be used to demonstrate those individuals with<br />

neurological dysfunction that may<br />

be amenable to HBO treatment.(14)<br />

HBOT has been used as an adjunct to radiationinduced<br />

necrosis of the brain which demonstrates<br />

its potential neuroprotective role.(15) The use of<br />

HBOT for bony injuries <strong>and</strong> soft tissue radiation<br />

injury was recommeded by Feldmeirer after a<br />

review of 74 studies in the literature. He further<br />

noted that there was increasing evidence in<br />

support of HBOT for radiation-induced brain<br />

necrosis.(16)<br />

Treatment frequency of HBOT has been found to<br />

be a factor in improving neuropsychiatric effects of<br />

chronic brain injury <strong>and</strong> this may occur via<br />

enhanced mitochondrial recovery. This benefit is<br />

proposed when HBO treatment is used at lower<br />

pressures <strong>and</strong> greater frequency. Many reports<br />

describe the use of ‚mild‛ hyperbaric oxygen<br />

therapy at pressures of 1.5 atmospheres or less<br />

<strong>and</strong> ongoing treatments.(17)<br />

This was illustrated by a pilot case study of a<br />

54-year-old male who had sustained a TBI one<br />

year previous, causing permanent neurological<br />

symptoms. Electrophysiological, behavioral, <strong>and</strong><br />

metabolic measures were obtained to evaluate the<br />

impact of HBOT on his neurocognitive function.<br />

After the first series of 20 treatments, the authors<br />

noted improvements in motor <strong>and</strong> sensory<br />

measures. These were paralleled by<br />

electrophysiological measures. The improvements<br />

were not sustained at one year. He then received<br />

a second series of 60 HBO treatments one year<br />

later.(18)<br />

Notable aspects of this case study are the<br />

documented measurable clinical improvements<br />

coincident with enhanced electrophysiological testing<br />

(P300 brainwave amplitude); however, there was<br />

no concomitant improvement in SPECT imaging<br />

seen.<br />

This may indicate that SPECT imaging is not the<br />

appropriate surrogate test to validate <strong>functional</strong><br />

2012

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!